BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12764397)

  • 41. Taking risks: primary prevention of cardiovascular events.
    Vallance P
    N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
    [No Abstract]   [Full Text] [Related]  

  • 42. Prescribing patterns for thiazide diuretics in a large health maintenance organization: relationship to participation as an ALLHAT clinical center.
    Petitti DB; Xie F; Barzilay JI
    Contemp Clin Trials; 2006 Oct; 27(5):397-403. PubMed ID: 16769253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Old myocardial infarction--focus on complication and secondary prevention].
    Fusazaki T
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():202-9. PubMed ID: 17948700
    [No Abstract]   [Full Text] [Related]  

  • 45. Basic approach to managing hyperglycemia for the nonendocrinologist.
    Deeg MA
    Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Taylor AL; Wright JT
    Circulation; 2005 Dec; 112(23):3654-60; discussion 3666. PubMed ID: 16330707
    [No Abstract]   [Full Text] [Related]  

  • 47. Case 2. Recurrence of myocardial infarction.
    Tanser P; Archer S; Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():24E-26E. PubMed ID: 10906622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
    Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The future of lipid-lowering therapy: the big picture.
    Kastelein JJ
    Neth J Med; 2003 May; 61(5 Suppl):35-9. PubMed ID: 12918548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [ALLHAT--remaining questions await answers].
    Nilsson PM
    Lakartidningen; 2004 Jan; 101(3):220, 223; discussion 224-7. PubMed ID: 14763096
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug therapy in the heart transplant recipient: Part III: common medical problems.
    Lindenfeld J; Page RL; Zolty R; Shakar SF; Levi M; Lowes B; Wolfel EE; Miller GG
    Circulation; 2005 Jan; 111(1):113-7. PubMed ID: 15630040
    [No Abstract]   [Full Text] [Related]  

  • 52. [Why not always diuretics?].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 2004 May; 124(10):1419-20. PubMed ID: 15195187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ALLHAT: a critical assessment.
    Sjöholm A
    Blood Press; 2004; 13(2):75-9. PubMed ID: 15182109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Possibility of preventing myocardial infarction].
    Ado MA; Privalova EV; Kosheleva VS
    Klin Med (Mosk); 1989 May; 67(5):32-4. PubMed ID: 2770206
    [No Abstract]   [Full Text] [Related]  

  • 55. Heart attack: what is your risk?
    Am Fam Physician; 2010 Aug; 82(3):275. PubMed ID: 20672792
    [No Abstract]   [Full Text] [Related]  

  • 56. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.
    Oparil S
    Hypertension; 2003 May; 41(5):1006-9. PubMed ID: 12695423
    [No Abstract]   [Full Text] [Related]  

  • 57. ALLHAT and AFFIRM.
    Liebson PR
    Prev Cardiol; 2003; 6(1):54-60. PubMed ID: 12624564
    [No Abstract]   [Full Text] [Related]  

  • 58. National Heart, Lung, and Blood Institute halts part of antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
    SoRelle R
    Circulation; 2000 Mar; 101(12):E9025. PubMed ID: 10736305
    [No Abstract]   [Full Text] [Related]  

  • 59. Improvement in current approaches to lipid lowering.
    Ansell BJ
    Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952
    [No Abstract]   [Full Text] [Related]  

  • 60. Prescription for heart attack survivors.
    Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):1-2, 7. PubMed ID: 11439689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.